Supporting the next phase of obesity care – driven by science and unmet needs

Modern Obesity Treatments are transforming weight management. GLP-1 and next-generation anti-obesity medicines can deliver clinically meaningful weight loss, but they also create new needs across the patient journey.

These treatments work partly by reducing appetite and calorie intake. Total calorie intake may fall by 16–39%, which supports weight loss — but also changes the gut environment. Less food intake, altered nutrient patterns, delayed gastric emptying and common gastrointestinal side effects create new needs around digestive comfort, gut health, nutritional resilience and long-term wellbeing.